Besides the typical whooping cough syndrome, infection with Bordetella pertussis or
immunization with whole-cell vaccines can result in a wide variety of physiological …

After the pertussis vaccine had been introduced in the 1940s and was shown to be very
successful in reducing the morbidity and mortality associated with the disease, the possibility …

Background Bordetella pertussis epidemics persist as transmission remains unabated
despite high acellular pertussis vaccination rates. BPZE1, a live attenuated intranasal …

Introduction Recombinant acellular pertussis (ap) vaccines containing genetically
inactivated pertussis toxin (PT gen) and filamentous hemagglutinin (FHA) with or without …

Neither immunization nor recovery from natural infection provides life-long protection
against Bordetella pertussis. Replacement of a whole-cell pertussis (wP) vaccine with an …

ÍSince the introduction of new generation pertussis vaccines, resurgence of pertussis has
been observed in many developed countries. Former whole-cell pertussis (wP) vaccines are …

Background A phase 2 randomized-controlled safety and immunogenicity trial evaluating
different doses of recombinant acellular pertussis vaccine containing genetically-inactivated …

As a tribute to Louis Pasteur on the occasion of the 200th anniversary of his birth, this article
summarizes the main contributions of scientists from Pasteur Institutes to the current …

Introduction Despite a decrease in infections caused by Bordetella pertussis due to COVID-
19 pandemic, booster vaccination of pregnant women is still recommended to protect …

Aim/objective This study investigates placental antibody transfer following recombinant
pertussis vaccination in pregnancy in a real-world setting. Methods This postmarketing …